Deals of the year 2007: AstraZeneca injects hope

The medicine proved not too bitter for AstraZeneca when it braved the debt markets in crisis-torn September. Waiting any longer might have been perilous.

Santander’s Italian disposal is the Real deal
Nigeria clears the decks
Big bet pays off for Fortis

GCA reaches out to buy US peer
Maxis maxes out
Mexico motors on local-currency deal
Bovespa floats on the wave it made

AstraZeneca plc (rated AA–/A1/AA–)
September 5, 2007
$8 billion equivalent issue:

Libor +30bp $650 million, due 2009
5.4% $1.75 billion, due 2012
5.9% $1.75 billion, due 2017
6.45% $2.75 billion, due 2037

September 12, 2007
5.125% €750 million, due 2017
Citi, Deutsche Bank, HSBC